Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: Immunogenicity and efficacy against lethal SEB intoxication in mice

Infection and Immunity

Volumn 64, Issue 5, 1996, Pages 1706-1713

  Lowell, George H ^a,c   Kaminski, Robert W ^a,b   Grate, Steven ^a   Hunt, Robert E ^a   Charney, Colleen ^a   Zimmer, Shanta ^a   Colleton, Curtis ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Pharmos Corporation   (United States)

^c Intellivax Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM POTASSIUM SULFATE; GALACTOSAMINE; IMMUNOGLOBULIN G; PROTEASOME; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS TOXOID;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS INFECTION;

EID: 0029935619     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.5.1706-1713.1996     Document Type: Article

References (53)

1. Abraham, E. 1992. Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 10:461-468.
2. Alving, C. R. 1991. Liposomes as carriers of antigens and adjuvants. J Immunol Methods 140:1-13.
3. Alving, C. R. 1995 Liposomes as vehicles for vaccines: induction of humoral. cellular and mucosal immunity, p. 47-58 In J. Moss, B. Iglewski, M. Vaughan, and A. T. Tu (ed.), Handbook of natural toxins, vol 8. Bacterial toxins and virulence factors in disease. Marcel Dekker, Inc, New York.
4. Bean, A. G. D., R. A. Freiberg, S. Andrade, M. Satish, and A. Zlotnik. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun 61:4937-4939.
5. Beisel, W. R. 1972. Pathophysiology of staphylococcal enterotoxin, type B. (SEB) toxemia after intravenous administration to monkeys. Toxicon 10: 433-440.
6. Chelen, C. J., Y. Fang, G. J. Freeman, H. Secrist, J. D. Marshall, P. T. Hwang, L. R. Frankel, R. H. DeKruyff, and D. T. Umetsu. 1995. Human alveolar macrophages present antigen ineffectively duc to defective expression of B7 costimulatory cell surface molecules. J. Clin. Invest. 95:1415-1421.
7. Choi, Y., J. A. Lafferty, J. R. Clements, J. K. Todd, E. W. Gelfand, J. Kappler, P. Marrack, and B. L. Kotzin. 1990. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 172:981-984.
8. Cuatrecasas, P. 1973 Gangliosides and membrane receptors for cholera toxin. Biochemistry 12:3558-3566.
9. Czerkinsky, C., M. W. Russell, N. Lycke, M. Lindblad, and J. M. Holmgren. 1989 Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun. 57:1072-1077
10. Dickinson, B. L., and J. D. Clements. 1995 Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun. 63:1617-1623
11. Edelman, R. 1992. An update on vaccine adjuvants in clinical trial. AIDS Res. Hum. Retroviruses 8:1409-1411.
12. Edelman, R., R. G. Russell, G. Losonsky, B. D. Tall, C. O. Tacket, M. M. Levine, and D. H. Lewis. 1993 Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradeable microspheres of poly (lactide-co-glycolide). Vaccine 11:155-158.
13. Edelman, R., and C. O. Tacket. 1990. Adjuvants. Int. Rev Immunol. 7:51-66.
14. Eldridge, J. H., R. M. Gilley, J. K. Staas, Z. Moldoveanu, J. A. Meulbroek, and T. R. Tice. 1989. Biodegradable microspheres, vaccine delivery system for oral immunization. Curr. Top. Microbiol Immunol. 146:59-66.
15. Eldridge, J. H., J. K. Staas, J. A. Meulbroek, T. R. Tice, and R. M. Gilley. 1991. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxm B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 59:2978-2986.
16. ElGuink, N., R. M. Kris, G. Goodman-Snitkoff, P. A. Small, Jr., and R. J. Mannino. 1989. Intranasal immunization with proteoliposomes protects against influenza. Vaccine 7:147-151.
17. Hajishengallis, G., S. K. Holingshead, T. Koga, and M. W. Russell. 1995. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154:4322-4332
18. Holmgren, J., N. Lycke, and C. Czerkinsky. 1993. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector. Vaccine 11:1179-1184.
19. Hunt, R. E., A. J. Johnson, M. Jett, J. Tseng, J. L. Komisar, C. L. Wilhelmsen, L. Pitt, and D. Ruble. 1993. Host respiratory protection for lethal staphylococcal enterotoxin B, p 71-78 In D Kamely, K. A. Bannister, and R. M. Sasmore (ed.). Army sciences: the new frontiers: military and civilian applications. Borg Biomedical Books, Saratoga, Wyo.
20. Kaminski, R., M. Levi, L. Loomis, K. Kersey, T. VanCott, D. Friedman, S. Amselem, G. Smith, B. Wahren, R. Redfield, D. Birx, and G. H. Lowell. 1996 Immunization with gp160 plus proteosorries, sub-micron emulsions and/or alum to enhance HIV peptide and protein antibody responses. Vaccine Res. 4:189-206.
21. Levi, R., E. Aboud-Pirak, C. Leclerc, G. H. Lowell, and R. Arnon. 1995. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine 13:1353-1359
22. Liu, C. T., and D. E. Hilmas. 1978. Effect of X-irradiation on survival of rabbits with staphylococcal B enterotoxemia. Radiat. Res. 76:402-409.
23. Livingston, P. O., M. J. Calves, F. H. Helling, W. D. Zollinger, M. S. Blake, and G. H. Lowell. 1993. GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3. Vaccine 11:1199-1204.
24. Lowell, G. 1994. Respiratory immunization with proteosome vaccines for HIV. shigella or staphylococcal enterotoxin B: induction of mueosal IgA and protection against lethal challenge in rodents and monkeys. In Novel vaccine strategies for mucosal immunization, genetic approaches and adjuvants. 2nd IBC International Conference. Rockville, Md.
25. Lowell, G. H. 1990 Proteosomes, hydrophobic anchors, iscoms, and liposomes for improved presentation of peptide and protein vaccines, p. 141-160. In G. C. Woodrow and M. M Levine (ed.), New generation vaccines. Marcel Dekker, Inc., New York.
26. Lowell, G. H., W. R. Ballou, L. F. Smith, R. A. Wirtz, W. D. Zollinger, and W. T. Hockmeyer. 1988. Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. Science 240:800-802.
27. Lowell, G. H., L. F. Smith, R. C. Seid, and W. D. Zollinger. 1988. Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants. J. Exp. Med. 167:658-663.
28. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
29. Mallett, C. P., T. L. Hale, R. Kaminski, T. Larsen, N. Orr, D. Cohen, and G. H. Lowell. 1995. Intranasal or intragastric immunization with proteosomeShigella lipopolysaccharide vaccines protect against lethal pneumonia in a murine model of Shigella infection. Infect. Immun. 63:2382-2386
30. Marrak, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
31. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamshchikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
32. Mattix, M. E., R. E. Hunt, C. L. Wilhelmsen, A. J. Johnson, and W. B. Baze. 1995. Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaco mulatta). Toxicol. Pathol. 23:262-268.
33. McGhee, J. R., and H. Kiyono. 1993. New perspectives in vaccine development: mucosal immunity to infections. Infect. Agents Dis. 2:55-73.
34. McQueen, C. E., E. C. Boedeker, R. Reid, D. Jarboe, M. Wolf, M. Le, and W. R. Brown. 1993. Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1. Vaccine 11:201-206.
35. Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune response in external secretions J. Clin. Immunol 7:265-276
36. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp Med. 175:91-98.
37. Murray, D. L., D. H. Ohlendorf, and P. M. Schlievert. 1995. Staphylococcal and streptococcal superantigens: their role in human diseases ASM News 61:229-235.
38. Neutra, M. R., and J.-P. Kraehenbuhl. 1992. Transepithelial transport and mucosal defence I: the role of M cells Trends Cell Biol. 2:134-138.
39. Orr, N., R. Arnon, G. Rubin, D. Cohen, H. Bercovier, and G. H. Lowell. 1994 Enhancement of anti-Shigella lipopolysaccharide (LPS) responses by addition of the cholera toxin B subunit to oral and intranasal proteosome-Shigella flexneri 2d LPS vaccines Infect. Immun. 62:5198-5200
40. Orr, N., G. Robin, D. Cohen, R. Arnon, and G. H. Lowell. 1993. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect. Immun. 61:2390-2395.
41. Roberts, M., A. Bacon, R. Rappuoli, M. Pizza, I. Cropley, G. Douce, G. Dougan, M. Marinaro, J. McGhee, and S. Chatfield. 1995. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/ 129G. is an effective mucosal adjuvant for intranasally delivered proteins. Infect. Immun. 63:2100-2108.
42. Russell, M. W., and H.-Y. Wu. 1991. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect. Immun. 59:4061-4070.
43. Schantz, E. J., W. G. Roessler, J. Wagman, L. Spero, D. A. Gunnery, and M. S. Bergdoll. 1965. Purification of staphylococcal enterotoxin B. Biochemistry 4:1011-1016.
44. Schlievert, P. M. 1993. Role of superantigens in human disease. J. Infect. Dis. 167:997-1002.
45. Shahin, R., M. Leef, J. Eldridge, M. Hudson, and R. Gilley. 1995. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres. Infect. Immun. 63: 1195-1200.
46. Spero, L., A. Johnson-Winegar, J. J. Schmidt. 1988. Enterotoxins of staphylococci, p. 131-163. In M. C Hardegree and A T Tu (ed.), Handbook of natural toxins, vol. IV. Marcel Dekker, Inc., New York.
47. Spero, L., D. L. Leatherman, and W. H. Adler. 1976. Mitogenicity of formalized toxoids of staphylococcal enterotoxin B. Infect Immun. 12:1018-1020.
48. Tseng, J., J. Komisar, R. Trout R. Hunt, J. Chen, A. Johnson, L. Pitt, and D. Ruble. 1995. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEE), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres Infect. Immun. 63:2880-2885.
49. U.S. Department of Health and Human Services. 1985. Guide to the care and use of laboratory animals, revised ed. U.S. Department of Health and Human Services publication 85-23 U S. Department of Health and Human Services, Washington, D.C.
50. Walker, R. I. 1994. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387-400.
51. Warren, J. R., L. Spero, and J. F. Metzger. 1973 Antigenicity of formaldehyde-inactivated staphylococcal enterotoxin B J. Immunol. 111:885-892
52. Wetzler, L. M., Y. Ho, and H. Reiser. Neisserial porins induce B lymphocytes to express co-stimulatory B7-2 molecules and to proliferate. J. Exp. Med., in press
53. Wu, H.-Y., and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun. 61:314-322.